Omeros reported $47.7M in Current Liabilities for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Current Liabilities Change
Acelrx Pharmaceuticals ACRX:US $ 15.19M 0.36M
Adamas Pharmaceuticals ADMS:US 21.82M 7.35M
Adma Biologics ADMA:US $ 18.19M 3.02M
Aerie Pharmaceuticals AERI:US $ 108.09M 14.72M
Alexion Pharmaceuticals ALXN:US $ 1426.2M 198.5M
Alnylam Pharmaceuticals ALNY:US $ 554.65M 59.82M
Biomarin Pharmaceutical BMRN:US $ 443.34M 13.31M
Cytokinetics CYTK:US $ 61.77M 25.84M
Dynavax Technologies DVAX:US $ 204.64M 95.22M
Gilead Sciences GILD:US $ 10214M 509M
Heron Therapeutics HRTX:US $ 82.14M 18.77M
Insmed INSM:US $ 99.66M 18.26M
Intercept Pharmaceuticals ICPT:US $ 145.28M 0.95M
Knight Therapeutics Inc GUD:CN C$ 117.77M 18.17M
Macrogenics MGNX:US $ 69.92M 16.88M
Mirati Therapeutics MRTX:US $ 180.87M 103.76M
Omeros OMER:US $ 47.7M 4.26M
Pacira Pharmaceuticals PCRX:US $ 228.69M 3.39M
Regulus Therapeutics RGLS:US $ 9.97M 0.1M
Rockwell Medical RMTI:US $ 34.04M 22.81M
Sangamo Biosciences SGMO:US $ 136.94M 4.1M
Sarepta Therapeutics SRPT:US $ 425.02M 60.29M
United Therapeutics UTHR:US $ 311.4M 9M
Vertex Pharmaceuticals VRTX:US $ 1836.45M 107.6M
Vital Therapies VTL:US $ 14.49M 1.87M
Xoma XOMA:US $ 6.29M 6.82M